Clinical Trial Update: Peptide Vaccination in Treating Patients With Esophageal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating peptide vaccination for esophageal cancer. The current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: University of Yamanashi | Conditions: Esophageal Cancer | Phase 1 | Status: UNKNOWN